ARGENX SE is 1.9x more valuable than BIOGEN INC. by market capitalization ($53.35 B vs $28.73 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | BIIB | ARGX |
|---|---|---|
| Market cap | $28.73 B | $53.35 B |
| US-listed rank | #480 | #306 |
| Revenue (latest FY) | $9.89B | - |
| Net income (latest FY) | $1.29B | - |
| Net margin | 13.1% | - |
| P/E (trailing FY) | 22.2 | - |
| SEC filings | 2,690 | 272 |
ARGENX SE is 1.9x more valuable than BIOGEN INC. by market capitalization ($53.35 B vs $28.73 B).
Full pages: BIOGEN INC. and ARGENX SE, or browse the full rankings.